Levine Cancer Institute’s Hematologic Oncology and Blood Disorders program includes more than a dozen nationally recruited specialists dedicated to treating blood disorders and blood cancers. Subspecialists provide care in specific malignancies, including leukemia, plasma cell disorders, transplantation and lymphoma, as well as expertise in non-malignant hematology.
Physicians meet regularly to discuss every patient's care and to develop a comprehensive treatment plan in consultation with the referring physician, which is unique for each patient.
A Leader in Clinical Trials
The Hematologic Oncology and Blood Disorders program places special emphasis on clinical trials. Physicians participate in national clinical research studies that test novel technologies and treatments, allowing families to stay close to home to access the best care. By the end of 2014, the Institute is expected to be one of the leading enrolling sites for blood cancer clinical trials in the country.
Region’s First BMT Unit
The Institute recently opened the region’s first adult blood and marrow transplantation (BMT) unit. The 16-bed, state-of-the-art unit is designed to minimize the risk of patients developing infection and other complications during the transplant process. Because a patient’s stay can last up to six weeks, the unit offers an exercise room, larger patient rooms for family members and a laundry room.